SEPTERNA INC (SEPN) Stock Fundamental Analysis

NASDAQ:SEPN • US81734D1046

27.5 USD
+1.74 (+6.75%)
At close: Feb 13, 2026
27.5 USD
0 (0%)
After Hours: 2/13/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SEPN. SEPN was compared to 191 industry peers in the Pharmaceuticals industry. SEPN has a great financial health rating, but its profitability evaluates not so good. SEPN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • SEPN had negative earnings in the past year.
  • SEPN had a positive operating cash flow in the past year.
SEPN Yearly Net Income VS EBIT VS OCF VS FCFSEPN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -12.88%, SEPN is in the better half of the industry, outperforming 64.40% of the companies in the same industry.
  • SEPN's Return On Equity of -14.00% is fine compared to the rest of the industry. SEPN outperforms 70.68% of its industry peers.
Industry RankSector Rank
ROA -12.88%
ROE -14%
ROIC N/A
ROA(3y)-30.64%
ROA(5y)N/A
ROE(3y)-35.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SEPN Yearly ROA, ROE, ROICSEPN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for SEPN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SEPN Yearly Profit, Operating, Gross MarginsSEPN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -10K -20K -30K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • SEPN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SEPN has more shares outstanding than it did 1 year ago.
  • SEPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SEPN Yearly Shares OutstandingSEPN Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M
SEPN Yearly Total Debt VS Total AssetsSEPN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • SEPN has an Altman-Z score of 18.90. This indicates that SEPN is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 18.90, SEPN belongs to the best of the industry, outperforming 87.43% of the companies in the same industry.
  • SEPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 18.9
ROIC/WACCN/A
WACC9.25%
SEPN Yearly LT Debt VS Equity VS FCFSEPN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 27.77 indicates that SEPN has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 27.77, SEPN belongs to the best of the industry, outperforming 94.76% of the companies in the same industry.
  • A Quick Ratio of 27.77 indicates that SEPN has no problem at all paying its short term obligations.
  • SEPN has a better Quick ratio (27.77) than 94.76% of its industry peers.
Industry RankSector Rank
Current Ratio 27.77
Quick Ratio 27.77
SEPN Yearly Current Assets VS Current LiabilitesSEPN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for SEPN have decreased strongly by -53868.89% in the last year.
  • SEPN shows a strong growth in Revenue. In the last year, the Revenue has grown by 611.92%.
EPS 1Y (TTM)-53868.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.13%
Revenue 1Y (TTM)611.92%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12113.07%

3.2 Future

  • SEPN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.02% yearly.
  • SEPN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 116.01% yearly.
EPS Next Y85.2%
EPS Next 2Y35.65%
EPS Next 3Y21.16%
EPS Next 5Y11.02%
Revenue Next Year5401.16%
Revenue Next 2Y930.97%
Revenue Next 3Y366.85%
Revenue Next 5Y116.01%

3.3 Evolution

SEPN Yearly Revenue VS EstimatesSEPN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
SEPN Yearly EPS VS EstimatesSEPN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SEPN. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SEPN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SEPN Price Earnings VS Forward Price EarningsSEPN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, SEPN is valued cheaper than 91.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.94
EV/EBITDA N/A
SEPN Per share dataSEPN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as SEPN's earnings are expected to grow with 21.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.65%
EPS Next 3Y21.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for SEPN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SEPTERNA INC

NASDAQ:SEPN (2/13/2026, 8:00:01 PM)

After market: 27.5 0 (0%)

27.5

+1.74 (+6.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-10
Earnings (Next)03-25
Inst Owners99.59%
Inst Owner Change0.03%
Ins Owners3.15%
Ins Owner Change0.35%
Market Cap1.23B
Revenue(TTM)22.05M
Net Income(TTM)-58.81M
Analysts82.86
Price Target34.53 (25.56%)
Short Float %4.53%
Short Ratio6.42
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-137.48%
Min EPS beat(2)-163.84%
Max EPS beat(2)-111.11%
EPS beat(4)1
Avg EPS beat(4)-68.2%
Min EPS beat(4)-163.84%
Max EPS beat(4)9.5%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-69.38%
Min Revenue beat(2)-98.97%
Max Revenue beat(2)-39.79%
Revenue beat(4)2
Avg Revenue beat(4)3.63%
Min Revenue beat(4)-98.97%
Max Revenue beat(4)114.71%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)12.11%
PT rev (3m)47.2%
EPS NQ rev (1m)-6.11%
EPS NQ rev (3m)-58.64%
EPS NY rev (1m)-0.81%
EPS NY rev (3m)-3378.57%
Revenue NQ rev (1m)-4.95%
Revenue NQ rev (3m)-47.14%
Revenue NY rev (1m)0.99%
Revenue NY rev (3m)-48.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 55.85
P/FCF 11.94
P/OCF 11.81
P/B 2.93
P/tB 2.93
EV/EBITDA N/A
EPS(TTM)-1.78
EYN/A
EPS(NY)-1.26
Fwd EYN/A
FCF(TTM)2.3
FCFY8.38%
OCF(TTM)2.33
OCFY8.47%
SpS0.49
BVpS9.38
TBVpS9.38
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.88%
ROE -14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 467.93%
ROA(3y)-30.64%
ROA(5y)N/A
ROE(3y)-35.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 66.94%
Cap/Sales 4.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 27.77
Quick Ratio 27.77
Altman-Z 18.9
F-Score5
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)237.63%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53868.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.13%
EPS Next Y85.2%
EPS Next 2Y35.65%
EPS Next 3Y21.16%
EPS Next 5Y11.02%
Revenue 1Y (TTM)611.92%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12113.07%
Revenue Next Year5401.16%
Revenue Next 2Y930.97%
Revenue Next 3Y366.85%
Revenue Next 5Y116.01%
EBIT growth 1Y-77.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.08%
EBIT Next 3Y-7.32%
EBIT Next 5YN/A
FCF growth 1Y-67.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-74.24%
OCF growth 3YN/A
OCF growth 5YN/A

SEPTERNA INC / SEPN FAQ

What is the fundamental rating for SEPN stock?

ChartMill assigns a fundamental rating of 4 / 10 to SEPN.


Can you provide the valuation status for SEPTERNA INC?

ChartMill assigns a valuation rating of 2 / 10 to SEPTERNA INC (SEPN). This can be considered as Overvalued.


Can you provide the profitability details for SEPTERNA INC?

SEPTERNA INC (SEPN) has a profitability rating of 1 / 10.